Abstract
Parenteral nutrition (PN) is a lifesaving or life-sustaining treatment, but complications from its use, including central line–associated bloodstream infections (CLABSIs), necessitate that care be taken to ensure its safety. Our institution developed strategies that aim to incorporate evidence-based practices to reduce the risk of CLABSIs in patients receiving PN. A retrospective evaluation was conducted to assess the implementation of these strategies. Overall, adherence to the risk-reduction strategies was high, and no patients receiving PN experienced CLABSI during the time of the study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
